1-5 of 5
Selwyn M. Vickers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo

Charles W. Kimbrough, Anil Khanal, Matthew Zeiderman, Bigya R. Khanal, Neal C. Burton, Kelly M. McMasters, Selwyn M. Vickers, William E. Grizzle, Lacey R. McNally
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4576–4585.
https://doi.org/10.1158/1078-0432.CCR-15-0314
Published: 14 October 2015
View article titled, Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes <em>In Vivo</em>
Open the PDF for Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes <em>In Vivo</em> in another window
Includes: Multimedia, Supplementary data
Journal Articles

CD133+ Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide

Sulagna Banerjee, Alice Nomura, Veena Sangwan, Rohit Chugh, Vikas Dudeja, Selwyn M. Vickers, Ashok Saluja
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2388–2399.
https://doi.org/10.1158/1078-0432.CCR-13-2947
Published: 30 April 2014
View article titled, CD133<sup>+</sup> Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide
Open the PDF for CD133<sup>+</sup> Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide in another window
Includes: Supplementary data
Journal Articles

Serum Biomarker Panels for the Detection of Pancreatic Cancer

Randall E. Brand, Brian M. Nolen, Herbert J. Zeh, Peter J. Allen, Mohamad A. Eloubeidi, Michael Goldberg, Eric Elton, Juan P. Arnoletti, John D. Christein, Selwyn M. Vickers, Christopher J. Langmead, Douglas P. Landsittel, David C. Whitcomb, William E. Grizzle, Anna E. Lokshin
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 805–816.
https://doi.org/10.1158/1078-0432.CCR-10-0248
Published: 15 February 2011
View article titled, Serum Biomarker Panels for the Detection of Pancreatic Cancer
Open the PDF for Serum Biomarker Panels for the Detection of Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer

Leo Christopher DeRosier, Donald J. Buchsbaum, Patsy G. Oliver, Zhi-Qiang Huang, Jeffrey C. Sellers, William E. Grizzle, Wenquan Wang, Tong Zhou, Kurt R. Zinn, Joshua W. Long, Selwyn M. Vickers
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5535s–5543s.
https://doi.org/10.1158/1078-0432.CCR-07-1075
Published: 17 September 2007
View article titled, Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer
Open the PDF for Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer in another window
Journal Articles

Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects

Carmelo Blanquicett, M. Wasif Saif, Donald J. Buchsbaum, Mohamad Eloubeidi, Selwyn M. Vickers, David C. Chhieng, Mark D. Carpenter, Jeffrey C. Sellers, Suzanne Russo, Robert B. Diasio, Martin R. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8773–8781.
https://doi.org/10.1158/1078-0432.CCR-05-0627
Published: 16 December 2005
View article titled, Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
Open the PDF for Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects in another window